市場調查報告書
商品編碼
1370366
生物晶片市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球生物晶片市場規模達169億美元。展望未來,IMARC Group預計到2028年市場規模將達到406億美元,2023-2028年年複合成長率(CAGR)為15.8%。慢性病的盛行率不斷上升、對個人化藥物的偏好不斷增加以及對早期檢測癌細胞的需求不斷增加是推動市場發展的一些關鍵因素。
生物晶片是指一種微型醫療設備,旨在在更短的時間內同時執行多個生化反應。它們包含排列在固體基質表面上的一組微測試位點或微陣列。它們以脫氧核糖核酸 (DNA)、蛋白質、酵素和晶片實驗室的形式被廣泛使用。它們結構緊湊、功能強大、快速、易於使用,並且能夠準確地提供關鍵見解。它們非常適合儲存個人醫療和財務訊息,並且可以輕鬆追蹤人類或動物。它們被植入體內,協助監測、分析和控制患者的健康狀況和體內的生物過程。除此之外,它們還有助於識別潛在危險、確保安全的環境和改善決策。因此,生物晶片在全球個體中的基因、腫瘤學、發炎診斷和分子分析中得到了應用。
目前,糖尿病、血壓和慢性阻塞性肺病(COPD)等慢性病盛行率不斷上升,是支持全球市場成長的關鍵因素之一。除此之外,生物晶片在基因組學、蛋白質組學和分子診斷領域的日益普及正在對市場產生積極影響。此外,生物晶片提供的各種好處,例如減少時間和金錢以及無需重型儀器即可提供高通量的能力,正在促進市場的成長。除此之外,全球醫療保健產業對省時且高品質設備的需求不斷增加。再加上人們越來越偏好個人化藥物和下一代定序(NGS)來治療個體中的多種疾病,正在推動市場的成長。除此之外,擴大採用生物晶片來早期檢測體內癌細胞,這為產業投資者提供了利潤豐厚的成長機會。此外,老年人口的不斷增加,以及世界各地對用於藥物開發和發現的生物晶片的需求不斷成長,正在提供良好的市場前景。此外,基於微流體的設備的生物醫學進步和晶片實驗室的創新在傳染病的初步診斷中提供快速結果正在推動市場的成長。
The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028. The growing prevalence of chronic diseases, increasing preferences for personalized medicines, and rising need for early detection of cancerous cells represent some of the key factors driving the market.
Biochips refer to a miniaturized medical device that is designed to perform several biochemical reactions simultaneously in less time. They comprise a collection of micro-test sites or microarrays, which are arranged on the surface of a solid substrate. They are widely available as deoxyribonucleic acid (DNA), protein, enzyme, and lab-on-a-chip. They are compact, powerful, fast, easy to use, and provide critical insights accurately. They are highly suitable for storing personal medical and financial information and can easily trace human beings or animals. They are implanted in the body and assist in monitoring, analyzing, and controlling the health of a patient and biological processes in the body. Besides this, they aid in identifying potential hazards, ensuring a safe environment, and improving decision-making. As a result, biochips find applications for gene, oncology, and inflammatory diagnosis and molecular analysis among individuals across the globe.
At present, rising prevalence of chronic diseases, such as diabetes, blood pressure, and chronic obstructive pulmonary disease (COPD), represents one of the key factors supporting the growth of the market around the world. Besides this, the growing utilization of biochips in genomics, proteomics, and molecular diagnostics among the masses is positively influencing the market. Additionally, various benefits offered by biochips, such as reduction of time and money and the ability to provide high throughput without any requirement of heavy instruments, is contributing to the growth of the market. Apart from this, there is a rise in demand for time-saving and high-quality devices in the healthcare industry across the globe. This, coupled with the increasing preference for personalized medicines and next-generation sequencing (NGS) to treat numerous diseases among individuals, is propelling the growth of the market. In addition to this, the rising adoption of biochips for early detection of cancerous cells in the body is offering lucrative growth opportunities to industry investors. Moreover, the increasing geriatric population, along with the growing demand for biochips for drug development and discovery around the world, is offering a favorable market outlook. Furthermore, the biomedical advancement in microfluidic-based devices and innovation in lab-on-a-chip to offer quick results at initial diagnosis of infectious disease is impelling the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global biochips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, fabrication technique, analysis method, application and end user.
DNA Chip
Protein Chip
Lab-On-a-Chip
Enzyme Chip
The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.
Microarray
Microfluidic
A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.
Electrophoresis
Luminescence
Mass Spectrometry
Electrical Signals
Magnetism
A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.
Molecular Analysis
Hybridization
Protein
Immunological
Biomolecules
Biomarker
Others
Diagnosis
Gene Diagnosis
Oncology
Inflammatory
Others
Non-Biological Usage
A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis (gene diagnosis, oncology, inflammatory, and others) accounted for the largest market share.
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostics Centers
Academic and Research Institutes
Others
A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Spain
Russia
Italy
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Others
Latin America
Mexico
Brazil
Argentina
Others
Middle East and Africa
Turkey
Saudi Arabia
United Arab Emirates
Others
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for biochips. Some of the factors driving the North America biochips market included the growing prevalence of lifestyle diseases, rising geriatric population, presence of several biotechnology companies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global biochips market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Thermo Fisher Scientific, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.